Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPγS binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to δ9-tetrahydrocannabinol

Journal of Molecular Neuroscience

Volumn 11, Issue 2, 1998, Pages 109-119

  Romero, Julián ^a   Berrendero, Fernando ^a   García Gil, Lucía ^a   Ramos, Jose A ^a   Fernández Ruiz, J Javier ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Autoradiography; Basal ganglia; Cannabinoid receptor agonist stimulated 35S GTP S binding; Cannabinoid receptor binding; Cannabinoid receptor mRNA levels; Cerebellum; In situ hybridization; 9 tetrahydrocannabinol

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; DRONABINOL; GUANOSINE 5' O (3 THIOTRIPHOSPHATE);

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; DRUG TOLERANCE; IN SITU HYBRIDIZATION; MALE; MOTOR DYSFUNCTION; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ANIMALIA; EUKARYOTA; RODENTIA;

EID: 0032469925     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/jmn:11:2:109     Document Type: Article

References (35)

1. 9-tetrahydrocannabinol without alteration of cannabinoid receptor binding or mRNA levels in whole brain. Pharmacol. Biochem. Behav. 46, 575-579.
2. Aceto M. D., Scates S. M., Lowe J. A., and Martin B. R. (1995) Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR141716A. Eur. J. Pharmacol. 282, R1,R2.
3. Crawley J. N., Corwin R. L., Robinson J. K., Felder C. C., Devane W., and Axelrod J. (1993) Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol. Biochem. Behav. 46, 967-972.
4. Dewey W. L. (1986) Cannabinoid pharmacology. Pharmacol Rev. 38, 151-178.
5. Fan F., Tao Q., Abood M., and Martin B. R. (1996) Cannabinoid receptor down regulation without alteration in the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice. Brain Res. 706, 13-20.
6. Fride E. and Mechoulam R. (1993) Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231, 313,314.
7. Gerfen C. R. (1992) D1 and D2 dopamine receptor regulation in striatonigral and striatopallidal neurons. Semin. Neurosci. 4, 109-118.
8. Glass M., Faull R. L. M., and Dragunow M. (1993) Loss of cannabinoid receptors in the substantia nigra in Huntington's disease. Neuroscience 56, 523-527.
9. Herkenham M., Lynn A. B., Little M. D., Johnson M. R., Melvin L. S., de Costa D. R., and Rice K. C. (1990) Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA 87, 1932-1936.
10. Herkenham M., Lynn A. B., Johnson M. R., Melvin L. S., de Costa B. R., and Rice K. C. (1991a) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563-583.
11. Herkenham M., Lynn A. B., de Costa B. R., and Richfield E. K. (1991b) Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547, 267-274.
12. Howlett A. C., Bidaut-Russell M., Devane W. A., Melvin L. S., Johnson M. R., and Herkenham M. (1990) The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci. 13, 420-423.
13. Jansen E. M., Haycock D. A., Ward S. J., and Seybold U. S. (1992) Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res. 575, 93-102.
14. Mailleux P. and Vanderhaeghen J.-J. (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization hystochemistry. Neuroscience 48, 655-668.
15. Mechoulam R., Hanus L., and Martin B. R. (1994) Search for endogenous ligands of the cannabinoid receptors. Biochem. Pharmacol. 48, 1537-1544.
16. 9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations. Pharmacol. Biochem. Behav. 45, 291-298.
17. Oviedo A., Glowa J., and Herkenham M. (1993) Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Brain Res. 616, 293-302.
18. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
19. 9-tetrahydrocannabinol to produce marked catalepsy in mice. Neuropharmacology 27, 1256-1270.
20. Pertwee R. G. (1995) Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors, in Cannabinoid Receptors (Pertwee R. G., ed.), Academic, New York, pp. 1-34.
21. Richfield E. K. and Herkenham M. (1994) Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Ann. Neurol. 36, 577-584.
22. 9-tetrahydrocannabinol. Pharmacol. Biochem. Behav. 47, 33-40.
23. Romero J., de Miguel R., Garcia-Palomero E., Fernández-Ruiz J. J., and Ramos J. A. (1995) Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. Brain Res. 694, 223-232.
24. Romero J., Garcia-Palomero E., Lin S. Y., Ramos J. A., Makriyannis A., and Fernández-Ruiz J. J. (1996a) Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand. Life Sci. 58, 1249-1257.
25. Romero J., Garcia-Palomero E., Fernández-Ruiz J. J., and Ramos J. A. (1996b) Involvement of GABA-B receptors in the motor inhibition produced by agonists of brain cannabinoid receptors. Behav. Pharmacol. 7, 299-302.
26. Romero J., de Miguel R., Ramos J. A., and Fernández-Ruiz J. J. (1997a) The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake. Life Sci. 62, 351-363.
27. 9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Mol. Brain Res. 46, 100-108.
28. Romero J., Garcia-Palomero E., Berrendero F., Garcia-Gil L., Hernández M. L., Ramos J. A., and Fernández-Ruiz J. J. (1997c) Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse 26, 317-323.
29. 35S]-guanylyl-5′-O-(g-thio)-triphosphate binding in the basal ganglia of aged rats. Neuroscience 84, 1075-1083.
30. Rubino T., Massi P., Patrini G., Venier I, Giagnoni G., and Parolaro D. (1994) Chronic CP-55,940 alters cannabinoid receptor-mRNA in the rat brain: an in situ hybridization study. Neuroreport 5, 2493-2496.
31. 35S]-GTPgS autoradiography in rat brain. J. Neurosci. 16, 8057-8066.
32. Smith P. B., Compton D. R., Welch S. P., Razdan R. K., Mechoulam R., and Martin B. R. (1994) The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270, 219-227.
33. 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. Eur. J. Pharmacol. 280, R13-R15.
34. 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptor. Brain Res. 544, 145-149.
35. 9-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats. Eur. J. Pharmacol. 250, 205-208.